Prostate Cancer Update A CME Audio Series and Activity

STATEMENT OF NEED/TARGET AUDIENCE:

Prostate cancer is one of the most rapidly evolving fields in urologic oncology. Published results from clinical trials lead to the emergence of new surgical and radiation therapy techniques and therapeutic agents, along with changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing urologist and radiation oncologist must be well informed of these advances. To bridge the gap between research and practice, Prostate Cancer Update utilizes one-on-one discussions with leading urologic oncology and radiation oncology investigators. By providing access to the latest research developments and expert perspectives, this CME program assists urologists and radiation oncologists in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES:

Upon completion of this activity, participants should be able to:

• Critically evaluate the clinical implications of emerging clinical trial data in prostate cancer screening, prevention and treatment.
• Inform prostate cancer patients about the specific risks and benefits of local and systemic therapies.
• Offer patients information regarding their prognosis with and without various therapeutic options.
• Provide individualized counseling to patients regarding the choice and timing of endocrine therapy.
• Discuss chemotherapy and biologic therapy options in the treatment of prostate cancer.

PURPOSE OF THIS ISSUE OF PROSTATE CANCER UPDATE:

The purpose of Issue 2 of Prostate Cancer Update is to support these global objectives by offering the perspectives of Drs Klotz, Zietman and Dreicer on the integration of emerging clinical research data into the management of prostate cancer.

ACCREDITATION STATEMENT:

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT:

Research To Practice designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.